BAE Systems rolls out first Armored Multi-Purpose Vehicle AMPV 51612161

Defence & Security News - BAE Systems
 
BAE Systems rolls out first Armored Multi-Purpose Vehicle AMPV
BAE Systems today rolled out the first prototype Armored Multi-Purpose Vehicle (AMPV) to the U.S. Army during a ceremony at the company’s York, Pennsylvania facility. The AMPV provides the Army with enhanced mobility, survivability, force protection, and combat superiority.
     
BAE Systems rolls out first Armored Multi Purpose Vehicle AMPV 640 001 The AMPV is a fully modern, highly flexible vehicle that includes five variants and is designed to replace the M113 family of vehicles (Photo BAE SYSTEMS)
     
“The AMPV prototype vehicles are the result of a highly collaborative relationship between the Army and our industry team,” said Beach Day, program director for AMPV at BAE Systems Combat Vehicles. “Through this relationship, we have been able to design a vehicle that provides a modern, robust solution that meets the needs of today’s soldier and of the future force.”

The AMPV is a fully modern, highly flexible vehicle that includes five variants and is designed to replace the Vietnam War-era M113 family of vehicles. It is a mature, cost-effective solution that leverages proven Bradley Infantry Fighting Vehicle and M109A7 Self-Propelled Howitzer designs. It meets the Army’s force protection and all-terrain mobility requirements that enable the AMPV to maneuver with the rest of the Armored Brigade Combat Team (ABCT). Maximizing commonality within the ABCT reduces developmental risk and provides significant cost savings to the Army.

In December 2014, BAE Systems was awarded a contract worth up to $1.2 billion from the Army for the Engineering, Manufacturing, and Development (EMD) and Low-Rate Initial Production (LRIP) phases of the AMPV program. The initial award of $383 million, under the EMD phase, is for development and production of 29 vehicles across all of the variants: general purpose, mission command, mortar carrier, medical evacuation, and medical treatment.

Today’s ceremony commemorated the rollout of the first of the general purpose variant. Deliveries of the prototype vehicles will continue into 2017, and developmental testing will run through 2018.